BioSpace News Archive

Business

The Wistar Institute and Batavia Biosciences Launch Collaboration to Manufacture and Distribute Wistar’s Rubella Vaccine Globally

The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines

May 4, 2020
·
4 min read
Policy

Trump Administration’s ‘Operation Warp Speed’ Zeroes in on 14 Possible COVID-19 Vaccines

The Hill reports that the six or eight selected will go into clinical trials, where “health experts are looking to weed out faulty candidates and come out with three or four vaccines that clear final testing to be used by early 2021.”

May 4, 2020
·
3 min read
·
Mark Terry
Deals

9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma

Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC

May 4, 2020
·
7 min read
Drug Development

Some Studies Suggest Intravenous Immunoglobulin Could Help Treat COVID-19

intravenous immunoglobulin is a common blood plasma product that is used to treat other immune disorders. Scientists are hoping to use it for COVID-19 treatment.

May 4, 2020
·
3 min read
·
Mark Terry
Deals

Italy’s Menarini Group Snaps Up Stemline Therapeutics for $667 Million

Shares of New York-based Stemline Therapeutics skyrocketed more than 153% in premarket trading after Italy’s Menarini Group announced a $667 million acquisition of the oncology-focused company.

May 4, 2020
·
2 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: May 4

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 4, 2020.

May 4, 2020
·
5 min read
·
BioSpace Editorial Staff
Biotech Beach

Researchers Eye Trifluoperazine as a Potential Treatment for Glioblastoma

UCLA Jonsson Comprehensive Cancer Center researchers and their colleagues announced on May 1 that they have discovered a drug that may help improve the overall survival rate in glioblastoma patients.

May 4, 2020
·
3 min read
·
Krystle Vermes
Pivotal to provide specialized clinical research services for new clinical trial with patients that have COVID-19

The clinical trial plans to include up to 300 patients in up to 25 European centers, has begun with first patients in Madrid

May 4, 2020
·
4 min read
Drug Development

Newron Pharma Abandons Rett Syndrome Program After Trial Fails to Hit Primary and Secondary Endpoints

“We are very disappointed in the topline results in the STARS study that did not meet the study endpoints,” said Ravi Anand, Newron’s chief medical officer.

May 4, 2020
·
3 min read
·
Mark Terry
FDA

Roche Wins Emergency Approval for its COVID-19 Antibody Test

The U.S. Food and Drug Administration green-lit Roche’s new Elecsys Anti-SARS-CoV-2 antibody test that will help determine whether or not people have been infected by the novel coronavirus and developed antibodies to the disease.

May 4, 2020
·
2 min read
·
Alex Keown